Gene and Cell Therapy Scientists are pioneering a new era in medical treatments by developing innovative therapies that target the underlying causes of diseases at the genetic and cellular levels. These scientists utilize cutting-edge techniques like gene editing, viral vectors, and stem cell manipulation to repair, replace, or alter genetic material to treat or prevent diseases. Their work covers a wide range of conditions, from genetic disorders such as cystic fibrosis to cancers, autoimmune diseases, and even neurodegenerative diseases. By modifying the patient’s cells or genes, they aim to restore normal function or even eradicate diseases that were previously considered untreatable. In their work, gene and cell therapy scientists collaborate with multidisciplinary teams, including biologists, clinicians, and regulatory experts, to ensure that their therapies are both safe and effective. They focus on overcoming the challenges of delivering genes or engineered cells to the right locations in the body, managing immune responses, and scaling up production for clinical use. With the growing potential of personalized medicine, these scientists play a pivotal role in transforming laboratory findings into real-world, life-changing treatments. As the field progresses, gene and cell therapy scientists continue to push boundaries, offering new hope for patients suffering from chronic and genetic diseases, and reshaping the future of medicine.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico